Gram-Negative Multidrug Resistant Pathogen and Its Treatment
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1986
Special Issue Editor
2. Department of Biomedicine and Biotechnology, Universidad de Alcalá, 28801 Alcalá de Henares, Spain
Interests: antimicrobial properties; biofilm; carbapenemase-producing Enterobacteriaceae; multidrug-resistant Pseudomonas aeruginosa; extensively drug-resistant Pseudomonas aeruginosa; gram-negative bacteria; antibiotic multidrug resistance; antibacterial potential; biofilm inhibition; Methicillin-resistant Staphylococcus aureus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
During the COVID-19 pandemic, the emergence of extremely resistant microorganisms and an increase in the incidence of carbapenem resistance were documented, possibly related to the increased use of broad-spectrum antibiotics in patients with COVID-19. At the same time, an increase in the rate of device-associated infections in intensive care units has been observed. The rapid global spread of bacteria that have acquired new resistance mechanisms is one of the greatest threats to global health today, causing infections that are impossible to treat. The World Health Organization (WHO) has declared antimicrobial resistance (AMR) among the top 10 threats to global health. The clinical development of new antimicrobials is exhausted, and very few of these are innovative.
The spread of carbapenemase-producing Enterobacteriaceae (CFE), multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Pseudomonas aeruginosa are a global health problem due to their ease of transmission and difficulty of treatment. Nosocomial infections associated with these Gram-negative bacteria have high morbidity and mortality rates, usually occurring in immunocompromised patients and those with multiple comorbidities and undergoing diagnostic-therapeutic procedures and prolonged hospital stays. These bacteria have an outstanding capacity to be selected and to propagate antimicrobial resistance in vivo. For all these reasons, the development of new antibiotics is a top priority.
Dr. Ramón Pérez-Tanoira
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbapenemase-producing Enterobacteriaceae
- multidrug-resistant Pseudomonas aeruginosa
- extensively drug-resistant Pseudomonas aeruginosa
- gram-negative bacteria
- multidrug-resistant
- antibiotic resistance
- extended-spectrum beta-lactamase
- antibacterial potential
- biofilm inhibition
- quorum sensing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
